Firefly Neuroscience (NASDAQ: AIFF) Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform
Measuring brain age with EEG and BNA™ could lead to a proactive and scalable approach to early screening for Alzheimer’s patients KENMORE, N.Y., Jan. 14, 2025 — Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: […]
